Concepedia

Il‐Kyu Choi

IC

Statistics

Publications

12

Citations

553

H-Index

12

Active since

2009

Affiliations

Hanyang University(Current)

Yonsei University

Harvard University

Dana-Farber Cancer Institute

Hangzhou Normal University

Il‐Kyu Choi is an author at Hanyang University specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2009–2023

12

Publications

12

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Il‐Kyu Choi, Zhe Wang, Qiang Ke et al. · Nature · 2020 · 85 citations · Full text

, , +14

Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4 <sup>+</sup> and CD8 <sup>+</sup> T cell responses

Il‐Kyu Choi, Zhe Wang, Qiang Ke et al. · Proceedings of the National Academy of Sciences · 2018 · 76 citations · Full text

, , +15

Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model

Eonju Oh, Il‐Kyu Choi, JinWoo Hong et al. · Oncotarget · 2016 · 67 citations · Full text

, , +17

Identification and Functional Characterization of Nuclear Mortalin in Human Carcinogenesis

Jihoon Ryu, Zeenia Kaul, A‐Rum Yoon et al. · Journal of Biological Chemistry · 2014 · 57 citations · Full text

, , +11

Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics

Peter Kim, Joseph J. Crivelli, Il‐Kyu Choi et al. · Mathematical Biosciences & Engineering · 2015 · 53 citations · Full text

, , +17

1–5 of 12